Zdrowie i gospodarka · 21/10/2003

FDA Releases Statement of Work for Evaluating First Cycle Review Performance

The FDA is seeking public comment on a document outlining a study to assess issues with its first cycle review process for new drug and biological applications, with the goal of awarding a contract to an independent consultant to perform the study.